D
Dolors Puigdemont
Researcher at Autonomous University of Barcelona
Publications - 54
Citations - 2378
Dolors Puigdemont is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Treatment-resistant depression & Major depressive disorder. The author has an hindex of 24, co-authored 52 publications receiving 2123 citations.
Papers
More filters
Journal ArticleDOI
Differential Association of Circadian Genes with Mood Disorders: CRY1 and NPAS2 are Associated with Unipolar Major Depression and CLOCK and VIP with Bipolar Disorder
Virginia Soria,Erika Martínez-Amorós,Geòrgia Escaramís,Joaquín Valero,Rosario Pérez-Egea,Cecilia García,Alfonso Gutiérrez-Zotes,Dolors Puigdemont,Mònica Bayés,José Manuel Crespo,José Manuel Crespo,Lourdes Martorell,Elisabet Vilella,Antonio Labad,Julio Vallejo,Julio Vallejo,Víctor Pérez,José M. Menchón,José M. Menchón,Xavier Estivill,Mònica Gratacòs,Mikel Urretavizcaya,Mikel Urretavizcaya +22 more
TL;DR: The data support the contribution of the circadian system to the genetic susceptibility to MD and suggest that different circadian genes may have specific effects on MD polarity.
Journal ArticleDOI
Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression.
Dolors Puigdemont,Rosario Pérez-Egea,Maria J. Portella,Joan Molet,Javier de Diego-Adeliño,Alexandre Gironell,Joaquim Radua,Beatriz Gómez-Ansón,Rodrigo Rodríguez,Maria Serra,Cristian de Quintana,Francesc Artigas,Enric Álvarez,Víctor Pérez +13 more
TL;DR: DBS fully remitted 50% of the patients at 1 yr, supporting its validity as a new therapeutic strategy for TRD, and all HAMD subscales without a significant incidence of side-effects.
Journal ArticleDOI
Double-Blind, Placebo-Controlled Study of Dialectical Behavior Therapy Plus Olanzapine for Borderline Personality Disorder
Joaquim Soler,Juan C. Pascual,Josefa Campins,J Barrachina,Dolors Puigdemont,Enrique Álvarez,Victor L. Perez +6 more
TL;DR: A combined psychotherapeutic plus pharmacological approach appears to lower dropout rates and constitutes an effective treatment for borderline personality disorder.
Journal ArticleDOI
A double-blind, randomized, placebo-controlled trial of Pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors
TL;DR: Although pindolol can accelerate the antidepressant action of selective serotonin reuptake inhibitors in previously untreated patients, it does not elicit a rapid clinical response in treatment-resistant patients within a 10-day period.
Journal ArticleDOI
Microstructural white-matter abnormalities associated with treatment resistance, severity and duration of illness in major depression
J. de Diego-Adeliño,Patricia Pires,Beatriz Gómez-Ansón,M. Serra-Blasco,Yolanda Vives-Gilabert,Dolors Puigdemont,Ana Martín-Blanco,Enric Álvarez,Víctor Pérez,Maria J. Portella +9 more
TL;DR: The notion that disruptions of white-matter microstructure, particularly in fronto-limbic networks, are associated with resistance to treatment and higher current and past burden of depression is supported.